Last updated on July 2019

Apollo™ Onyx™ Delivery Micro Catheter Post Market Safety Study NV-APL001

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Aneurysm
  • Gender: Male or Female

Inclusion Criteria:

  • The Subject or Subject’s legally authorized representative has signed and dated an informed consent form
  • The Subject has a confirmed diagnosis of a brain AVM
  • The Subject is clinically and neurologically stable for a minimum of 48 hours prior to embolization
  • The Subject has a life expectancy of at least 1 year
  • The Subject agrees to and is capable of completing all study-required procedures

Exclusion Criteria:

  • Current participation in another investigational drug or device study that evaluates treatments for brain AVMs or other cerebrovascular disease
  • The Subject has a bleeding disorder
  • The Subject is not a candidate for the use of vasodilators

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.